These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Grieder FB; Vogel SN Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925 [TBL] [Abstract][Full Text] [Related]
32. A single amino acid change in the E2 glycoprotein of Venezuelan equine encephalitis virus affects replication and dissemination in Aedes aegypti mosquitoes. Woodward TM; Miller BR; Beaty BJ; Trent DW; Roehrig JT J Gen Virol; 1991 Oct; 72 ( Pt 10)():2431-5. PubMed ID: 1919525 [TBL] [Abstract][Full Text] [Related]
33. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse. Charles PC; Walters E; Margolis F; Johnston RE Virology; 1995 Apr; 208(2):662-71. PubMed ID: 7747437 [TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters. Jackson AC; SenGupta SK; Smith JF Vet Pathol; 1991 Sep; 28(5):410-8. PubMed ID: 1750167 [TBL] [Abstract][Full Text] [Related]
36. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1. Davis NL; Brown KW; Greenwald GF; Zajac AJ; Zacny VL; Smith JF; Johnston RE Virology; 1995 Sep; 212(1):102-10. PubMed ID: 7676619 [TBL] [Abstract][Full Text] [Related]
37. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543 [TBL] [Abstract][Full Text] [Related]